3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
CNS
1
Conditions
Urinary Tract Infections
1
Urinary Bladder Neoplasms
1
Prostatic Neoplasms
1
Infections
1
Interventions
Caspofungin
3
liposomal amphotericin B
2
Itraconazole
2
Antibiotic Prophylaxis
2
Voriconazole
1
Valacyclovir
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Therapeutics
1
Stents
1
Ribavirin
1
Polymerase Chain Reaction
1
Pentetic Acid
1
Palivizumab
1
Nephrotomy
1
Nephrostomy, Percutaneous
1
Moxifloxacin
1
Minocycline
1
Levofloxacin
1
Immunologic Techniques
1
Heparin
1
Health Information Exchange
1
Fosfomycin
1
Fluconazole
1
Flow Cytometry
1
ER 30346
1
Docosahexaenoic Acids
1
Cystectomy
1
Ciprofloxacin
1
Amoxicillin-Potassium Clavulanate Combination
1
Amdinocillin Pivoxil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Infections
×
Fosfomycin
×
Genitourinary
×
Clear all
NCT03228108
2022-05-10
pro-SWAP
Radboud University Medical Center
Phase 4
Completed
1,538 enrolled